Gene · 3777
Papers1,851
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,851
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of potential drug targets and possible drugs for esophageal carcinoma from genetic insights: a comprehensive two-sample Mendelian randomization study. | Discov Oncol | 2025 | 40853405 | PubTator, text mining | PubMed |
| Druggable genome-wide Mendelian randomization integrating GWAS and eQTL/pQTL data identifies targets for lung squamous cell carcinoma. | Sci Rep | 2025 | 40820226 | PubTator, text mining | PubMed |
| Comorbidity of hypertension and lung cancer: interplay of genetics and environment. | Discov Oncol | 2025 | 40804226 | PubTator, text mining | PubMed |
| Exploring causal associations between nuclear magnetic resonance biomarkers and colorectal cancer risk. | Metabolomics | 2025 | 40794337 | PubTator, text mining | PubMed |
| Association Between Omega-3 Polyunsaturated Fatty Acids and Myopia: Results From the Two-Sample and Multi-Tissue Genomic Mendelian Randomization Study and KNHANES. | Food Sci Nutr | 2025 | 40792044 | PubTator, text mining | PubMed |
| Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for calcium pyrophosphate deposition disease. | Clin Rheumatol | 2025 | 40768106 | PubTator, text mining | PubMed |
| Comprehensive characterization of multi-omics landscapes between gut microbial metabolites and the druggable genome in sepsis. | Front Immunol | 2025 | 40761792 | PubTator, text mining | PubMed |
| Exploring Esketamine's Therapeutic Role for Perinatal Depression via TASK-1 Tandem Pore Potassium Channels. | ACS Chem Neurosci | 2025 | 40734344 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Biomarkers in Hypertension Impact on the Effectiveness of Individualized Therapy: A Systematic Review. | J Cardiovasc Pharmacol | 2025 | 40720628 | PubTator, text mining | PubMed |
| PARK7 is a Key Regulator of Oxidative Stress - Related Breast Cancer Risk: A Multi-Omics Study. | J Cancer | 2025 | 40657364 | PubTator, text mining | PubMed |
| Identification of Potential Therapeutic Targets for Coronary Atherosclerosis from an Inflammatory Perspective Through Integrated Proteomics and Single-Cell Omics. | Int J Mol Sci | 2025 | 40649979 | PubTator, text mining | PubMed |
| KU124 (9,10,10-trioxo-N-(2-phenylphenyl)thioxanthene-3-carboxamide) as a novel inhibitor of TASK-1. | Front Pharmacol | 2025 | 40635742 | PubTator, text mining | PubMed |
| Integrating Genetic and Single-Cell Genomic Data to Reveal Brain Cell-Specific Regulation of Attention-Deficit/Hyperactivity Disorder Risk in the Prefrontal Cortex. | Brain Behav | 2025 | 40621632 | PubTator, text mining | PubMed |
| Whole exome sequencing unravels genetic architecture and its clinical implications in pediatric pulmonary arterial hypertension. | Int J Cardiol | 2025 | 40516660 | PubTator, text mining | PubMed |
| Integrating Expression Quantitative Trait Loci and Genome-Wide Association Study Identifies Druggable Genes for Tinnitus. | Otol Neurotol | 2025 | 40480287 | PubTator, text mining | PubMed |
| Multiomic Underpinnings of Drug Targets for Intracranial Aneurysm: Evidence From Diversified Mendelian Randomization. | CNS Neurosci Ther | 2025 | 40346920 | PubTator, text mining | PubMed |
| Therapeutic Target Discovery for Multiple Myeloma: Identifying Druggable Genes via Mendelian Randomization. | Biomedicines | 2025 | 40299486 | PubTator, text mining | PubMed |
| Potential drug targets for Neuromyelitis optica spectrum disorders (NMOSD): A Mendelian randomization analysis. | PLoS One | 2025 | 40294019 | PubTator, text mining | PubMed |
| A strategy for evaluating the impact of processing of Chinese meteria medica on meridian tropism: the influence of salt-water processing of phellodendri chinensis cortex on renal transport proteins. | Front Pharmacol | 2025 | 40260384 | PubTator, text mining | PubMed |
| Potential therapeutic targets for bladder cancer: a proteome-wide Mendelian randomization study. | Am J Cancer Res | 2025 | 40226474 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3777/papers?page=7